The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(3-(3-Methylbut-2-en-1-yl)-5-((4-(trifluoromethoxy)-benzyl)carbamoyl)phenyl)acrylic Acid ID: ALA4532211
Chembl Id: CHEMBL4532211
PubChem CID: 135304444
Max Phase: Preclinical
Molecular Formula: C23H22F3NO4
Molecular Weight: 433.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)=CCc1cc(/C=C/C(=O)O)cc(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1
Standard InChI: InChI=1S/C23H22F3NO4/c1-15(2)3-4-17-11-18(7-10-21(28)29)13-19(12-17)22(30)27-14-16-5-8-20(9-6-16)31-23(24,25)26/h3,5-13H,4,14H2,1-2H3,(H,27,30)(H,28,29)/b10-7+
Standard InChI Key: LHORRWNZWXDXQU-JXMROGBWSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.43Molecular Weight (Monoisotopic): 433.1501AlogP: 5.12#Rotatable Bonds: 8Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.72CX Basic pKa: ┄CX LogP: 6.09CX LogD: 2.80Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -0.03
References 1. Verma K, Zang T, Penning TM, Trippier PC.. (2019) Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia., 62 (7): [PMID:30836001 ] [10.1021/acs.jmedchem.9b00090 ]